Literature DB >> 22696047

Biological roles of liver X receptors in immune cells.

Mónica Pascual-García1, Annabel F Valledor.   

Abstract

Liver X receptors (LXRs) are members of the nuclear receptor superfamily that are activated by specific oxysterols. LXRs heterodimerize with retinoid X receptors to regulate positively the expression of a variety of target genes, many of which are involved in lipid and glucose metabolism. In the last few years, new targets of LXR activation have been identified with roles in the modulation of immune responses. Moreover, LXRs mediate repression of inflammatory pathways through mechanisms collectively known as transrepression. Here, we revise recent findings on the impact of LXR activation on immune responses, with an emphasis on advances in the understanding of the molecular mechanisms that mediate these effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696047     DOI: 10.1007/s00005-012-0179-9

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  13 in total

Review 1.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 2.  Stress as an immunomodulator: liver X receptors maybe the answer.

Authors:  Issam Nessaibia; Allan Fouache; Jean-Marc A Lobaccaro; Abdelkrim Tahraoui; Amalia Trousson; Maâmar Souidi
Journal:  Inflammopharmacology       Date:  2018-11-22       Impact factor: 4.473

3.  Activation of LXRs Reduces Oxysterol Lipotoxicity in RPE Cells by Promoting Mitochondrial Function.

Authors:  Lirong Xie; Qing Gu; Xingwei Wu; Lili Yin
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

4.  The Liver X Receptor Is Upregulated in Monocyte-Derived Macrophages and Modulates Inflammatory Cytokines Based on LXRα Polymorphism.

Authors:  Hyoun-Ah Kim; Wook-Young Baek; Mi-Hwa Han; Ju-Yang Jung; Chang-Hee Suh
Journal:  Mediators Inflamm       Date:  2019-02-28       Impact factor: 4.711

5.  Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.

Authors:  M C Gage; N Bécares; R Louie; K E Waddington; Y Zhang; T H Tittanegro; S Rodríguez-Lorenzo; A Jathanna; B Pourcet; O M Pello; J V De la Rosa; A Castrillo; I Pineda-Torra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-27       Impact factor: 11.205

6.  Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics.

Authors:  Mohammad Bagher Sadeghi; Alireza Nakhaee; Ramin Saravani; Saman Sargazi
Journal:  J Diabetes Metab Disord       Date:  2021-01-27

7.  Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells.

Authors:  V Derangère; A Chevriaux; F Courtaut; M Bruchard; H Berger; F Chalmin; S Z Causse; E Limagne; F Végran; S Ladoire; B Simon; W Boireau; A Hichami; L Apetoh; G Mignot; F Ghiringhelli; C Rébé
Journal:  Cell Death Differ       Date:  2014-08-15       Impact factor: 15.828

8.  Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils.

Authors:  Gonzalo Alba; María Edith Reyes; Consuelo Santa-María; Remedios Ramírez; Isabel Geniz; Juan Jiménez; José Martín-Nieto; Elízabeth Pintado; Francisco Sobrino
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.

Authors:  Benoit Pourcet; Matthew C Gage; Theresa E León; Kirsty E Waddington; Oscar M Pello; Knut R Steffensen; Antonio Castrillo; Annabel F Valledor; Inés Pineda-Torra
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

10.  Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells.

Authors:  Wan-Yun Gao; Pei-Yi Chen; Hao-Jen Hsu; Ching-Yen Lin; Ming-Jiuan Wu; Jui-Hung Yen
Journal:  Biomedicines       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.